Radioactive drugs in drug development research: Quality assurance issues

J. Baranowska-Kortylewicz

doi:10.2174/138955707780059862

Radioactive drugs in drug development research: Quality assurance issues

J. Baranowska-Kortylewicz

Research output: Contribution to journal › Review article

4 Scopus citations

Abstract

Increasing number of new drugs, drug formulations and drug delivery systems is evaluated using noninvasive imaging methods. A successful use of new drugs and radiopharmaceuticals depends on their proven quality. This review provides a brief outline of the quality control procedures required for radiolabeled drugs within the context of the existing regulations.

Original language	English (US)
Pages (from-to)	231-244
Number of pages	14
Journal	Mini-Reviews in Medicinal Chemistry
Volume	7
Issue number	3
DOIs	https://doi.org/10.2174/138955707780059862
State	Published - Mar 2007

Keywords

Drug development
Quality assurance
Quality control
Radioactive drugs
Radiopharmaceuticals

ASJC Scopus subject areas

Molecular Medicine
Pharmacology
Drug Discovery
Cancer Research

Access to Document

10.2174/138955707780059862

Fingerprint Dive into the research topics of 'Radioactive drugs in drug development research: Quality assurance issues'. Together they form a unique fingerprint.

Cite this

Baranowska-Kortylewicz, J. (2007). Radioactive drugs in drug development research: Quality assurance issues. Mini-Reviews in Medicinal Chemistry, 7(3), 231-244. https://doi.org/10.2174/138955707780059862

@article{614b569b00eb4c4495bc4e909ab15997,

title = "Radioactive drugs in drug development research: Quality assurance issues",

abstract = "Increasing number of new drugs, drug formulations and drug delivery systems is evaluated using noninvasive imaging methods. A successful use of new drugs and radiopharmaceuticals depends on their proven quality. This review provides a brief outline of the quality control procedures required for radiolabeled drugs within the context of the existing regulations.",

keywords = "Drug development, Quality assurance, Quality control, Radioactive drugs, Radiopharmaceuticals",

author = "J. Baranowska-Kortylewicz",

year = "2007",

month = mar,

doi = "10.2174/138955707780059862",

language = "English (US)",

volume = "7",

pages = "231--244",

journal = "Mini-Reviews in Medicinal Chemistry",

issn = "1389-5575",

publisher = "Bentham Science Publishers B.V.",

number = "3",

}

TY - JOUR

T1 - Radioactive drugs in drug development research

T2 - Quality assurance issues

AU - Baranowska-Kortylewicz, J.

PY - 2007/3

Y1 - 2007/3

N2 - Increasing number of new drugs, drug formulations and drug delivery systems is evaluated using noninvasive imaging methods. A successful use of new drugs and radiopharmaceuticals depends on their proven quality. This review provides a brief outline of the quality control procedures required for radiolabeled drugs within the context of the existing regulations.

AB - Increasing number of new drugs, drug formulations and drug delivery systems is evaluated using noninvasive imaging methods. A successful use of new drugs and radiopharmaceuticals depends on their proven quality. This review provides a brief outline of the quality control procedures required for radiolabeled drugs within the context of the existing regulations.

KW - Drug development

KW - Quality assurance

KW - Quality control

KW - Radioactive drugs

KW - Radiopharmaceuticals

UR - http://www.scopus.com/inward/record.url?scp=33947704573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947704573&partnerID=8YFLogxK

U2 - 10.2174/138955707780059862

DO - 10.2174/138955707780059862

M3 - Review article

C2 - 17346216

AN - SCOPUS:33947704573

VL - 7

SP - 231

EP - 244

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 3

ER -